Site Map | Malaria FAQ | Info Request | Donate for Malaria | RBM Partnership Newsletter
Home
Search:
The RBM Partnership Global malaria advocacy Country action Commodity Services Publications and multimedia
Commodity Services
ACTs
Nets & insecticides
RDTs
Procurement & training
Artemisia
Database reports
ACTs

The following ACTs are currently recommended by WHO for the treatment of uncomplicated falciparum malaria (alphabetical order):

  • artemether-lumefantrine,
  • artesunate + amodiaquine,
  • artesunate + mefloquine,
  • artesunate + sulfadoxine–pyrimethamine.

Links & resources:

Responsibly improving access to ACTs in the private sector

Report of the MoH (Uganda)-MMV Workshop Series

 

Affordable Medicines Facility – malaria (AMFm)

Technical Design

 

Global Fund Grants for Malaria

Summary of Lessons Learned in the Implementation of ACT Policies in:
Ghana,
Nigeria,
Guinea-Bissau,
Summary

WHO GUIDELINES:

WHO informal consultation with manufacturers of artemisininbased pharmaceutical products in use for the treatment of malariaWHO informal consultation with manufacturers of artemisininbased pharmaceutical products in use for the treatment of malaria
WHO
August 2007 [English]

Guidelines for the treatment of malariaGuidelines for the treatment of malaria
WHO
January 2006 [English]

WHO AFRO RecommendationsRecommendations on the use of Sulfadoxine-Pyrimethamine (SP) for Intermittent Preventive Treatment during Pregnancy (IPT) in areas of moderate to high resistance to SP in the African Region
WHO AFRO
October 2005 [English]

Implementation GuideChanging Malaria Treatment Policy to Artemisinin-Based Combinations
An Implementation Guide
December 2005 Acrobat logo [English] [Français] [Portuguesa]

The Use of Antimalarial DrugsThe Use of Antimalarial Drugs
WHO; 2001
Acrobat logo [English] [Français]

Valid XHTML 1.0 Strict

Top of Page Site Map | Malaria FAQ | Info Request | Disclaimer | WHO/Global Malaria Programme